Concepedia

J. Cianfrogna

JC

Statistics

Publications

2

Citations

336

H-Index

2

Active since

2008

Affiliations

Pfizer (United States)(Current)

J. Cianfrogna is an author at Pfizer (United States) specializing in phosphodiesterase inhibition, pharmacology, and pharmacological potency.

Publications per year

2008–2011

2

Publications

2

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

C J Schmidt, Douglas S. Chapin, J. Cianfrogna et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 284 citations

, , +13

Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of Schizophrenia

Christopher J. Helal, Zhijun Kang, Xinjun Hou et al. · Journal of Medicinal Chemistry · 2011 · 52 citations · Full text

, , +17

1–2 of 2